Complicated Grief Among Children After a Death From Cancer or Another Cause: A Longitudinal and Prospective Study (CAPS) (CAPS)

July 22, 2021 updated by: University Hospital, Toulouse

Risk Factors for Complicated Grief After a Death From Cancer or an Other Cause: A Longitudinal and Prospective Study Among Children and Their Parents

The purpose of this study is to identify risk factors of Complicated Grief (CG) among children and adolescents who lost a parent to cancer or from an other cause.

Study Overview

Status

Completed

Conditions

Detailed Description

Although the intensity of the grief and life disruption usually subsides in the months following the loss of a loved one, approximately 7% of bereaved individuals will continue to experience persistent and intense grief-related symptoms associated with marked distress and functional impairment years after the death.

While several studies aimed to evaluate risk factors of CG among adults, little is known regarding CG among children and adolescents. Therefore, prospective research directly examining the impact of bereavement on post-loss psychiatric symptoms, including CG, post-traumatic-stress disorder (PTSD), depression, attentional and behavioral avoidance among children are needed. Improving our understanding of CG risk factors among children will help direct healthcare professionals' clinical attention toward screening and care of this underserved population.

Furthermore, identifying mechanisms explaining why cancer bereaved children may be at greater risk for persistent psychological distress and CG will inform the development of preventive, early intervention and treatment strategies.

Participants will be recruited to the Child and Adolescent grief counseling of the College Hospital of Toulouse as well as with the Team Regional Resource Pediatric Palliative Care "Enfant-Do". At 3, 6 and 12 months post-loss, children and their parent will be invited to complete questionnaires assessing peritraumatic dissociative experiences, peritraumatic distress, security attachment, symptoms of CG, symptoms of PTSD and attentional avoidance.

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toulouse, France, 31000
        • Psychiatrie de l'enfant et de l'adolescent

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 17 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Children :

  • Having lost a parent within the last 3 months
  • Signed consent form from the parent
  • To have health care coverage by the French social security

Parents :

  • Signed consent form
  • Having lost mother or father of the child within the last 3 months

Exclusion Criteria:

Children:

  • Both parents are dead
  • Medical disease
  • Ongoing legal procedure regarding the death

Parents :

  • Decline to take part to the study
  • Mental retardation or schizophrenia
  • Ongoing legal procedure regarding the death

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: children who lost a parent to cancer
Children will complete scales, questionnaires and inventory at 3 months post-loss and only 2 scales at 6 and 12 month post-loss
Children will complete scales, questionnaires and inventory at 3 months post-loss and only 2 scales at 6 and 12 month post-loss
Other Names:
  • Inventory
ACTIVE_COMPARATOR: children who lost a parent not to cancer
Children will complete scales, questionnaires and inventory at 3 months post-loss and only 2 scales at 6 and 12 month post-loss
Children will complete scales, questionnaires and inventory at 3 months post-loss and only 2 scales at 6 and 12 month post-loss
Other Names:
  • Inventory

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inventory of Complicated Grief
Time Frame: 6 months post-loss
Complicated Grief symptoms at 6 months post-loss among children aged from 6 to 17 years Measured by the Inventory of Complicated Grief
6 months post-loss

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inventory of Complicated Grief for Evaluation of paths of grief symptoms developement
Time Frame: At 3 and 12 months post-loss

Analysed symptoms and divided subject between 4 groups according to their symptoms.

Group 1 : High levels of grief symptoms at 3 months wich will decrease at 12 months Group 2 : Low levels of grief symptoms at 3 months wich will stay low at 12 months Group 3 : High levels of grief symptoms at 3 months wich will stay high at 12 months Group 4 : Low levels of grief symptoms at 3 months wich will increase at 12 months

At 3 and 12 months post-loss
Influence of grief symptoms of the parent staying in life
Time Frame: At 3 months and 12 months post-loss

Evaluation of the influence of grief symptoms of the parent staying in life on the level of complicated grief symptoms development (i) One group of children will have high levels of grief symptoms at T0 which will decrease over the time.

(ii) One group will have low levels of grief symptoms at T0 which will remain low over the time.

(iii) One group will have high levels of grief symptoms at T0 which will remain high over the time.

(iiii) One group will have low levels of grief symptoms at T0 which will increase over the time.

At 3 months and 12 months post-loss
Evaluation of the impact of the cause of parents death (cancer or other cause) on complicated grief symptoms development.
Time Frame: At 6 and 12 months post-loss
Questionnaire will be used to measure these symptoms : Inventory of Complicated Grief
At 6 and 12 months post-loss
Evaluation of the impact of the cause of parents death (cancer or other cause) on post-traumatic stress developement.
Time Frame: At 6 and 12 months post-loss
Questionnaires will be used to measure these symptoms : Peritraumatic Dissociative Experiences Questionnaire and Peritraumatic Distress Inventory
At 6 and 12 months post-loss
Evaluation of the impact of the cause of parents death (cancer or other cause) on depression developement.
Time Frame: At 6 and 12 months post-loss
Questionnaire will be used to measure these symptoms : Children Depression Inventory
At 6 and 12 months post-loss
Determined if early factors could explain differences of symptoms of complicated grief between the cause of death of the parent (cancer or another cause)
Time Frame: At 3 months post-loss
Questionnaire will be used to measure these symptoms : Inventory of Complicated Grief
At 3 months post-loss
Determined if early factors could explain differences of symptoms of post-traumatic stress developement between the cause of death of the parent (cancer or another cause)
Time Frame: At 3 months post-loss
Questionnaire will be used to measure these symptoms : Peritraumatic Dissociative Experiences Questionnaire and Peritraumatic Distress Inventory
At 3 months post-loss
Determined if early factors could explain differences of symptoms of depression developement between the cause of death of the parent (cancer or another cause)
Time Frame: At 3 months post-loss
Questionnaire will be used to measure these symptoms : Children Depression Inventory
At 3 months post-loss

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean-Philippe RAYNAUD, MD, University Hospital, Toulouse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 1, 2015

Primary Completion (ACTUAL)

April 1, 2020

Study Completion (ACTUAL)

May 1, 2020

Study Registration Dates

First Submitted

May 27, 2016

First Submitted That Met QC Criteria

October 30, 2017

First Posted (ACTUAL)

November 6, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 26, 2021

Last Update Submitted That Met QC Criteria

July 22, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • RC31/15/7458

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Grief

Clinical Trials on Scales, questionnaires and inventory

Subscribe